Real-World Effectiveness of Eptinezumab after Treatment with Subcutaneous CGRP Monoclonal Antibodies in Patients with Migraine

被引:0
|
作者
Casaletto, Emily [1 ]
Yang, Qiu Zi [1 ]
Waters, John [1 ]
Curran, John [1 ]
Lowe, Austin [1 ]
Yuan, Hsiangkuo [1 ]
机构
[1] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA USA
关键词
D O I
10.1212/WNL.0000000000203712
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P12-12.009
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world
    Caronna, Edoardo
    Gallardo, Victor Jose
    Egeo, Gabriella
    Vazquez, Manuel Millan
    Castellanos, Candela Nieves
    Membrilla, Javier A.
    Vaghi, Gloria
    Rodriguez-Montolio, Joana
    Fabra, Neus Fabregat
    Sanchez-Caballero, Francisco
    Sanchez, Alex Jaimes
    Munoz-Vendrell, Albert
    Oliveira, Renato
    Garate, Gabriel
    Gonzalez-Osorio, Yesica
    Guisado-Alonso, Daniel
    Ornello, Raffaele
    Thunstedt, Cem
    Fernandez-Lazaro, Iris
    Torres-Ferrus, Marta
    Alpuente, Alicia
    Torelli, Paola
    Aurilia, Cinzia
    Pere, Raquel Lamas
    Castrillo, Maria Jose Ruiz
    De Icco, Roberto
    Sances, Grazia
    Broadhurst, Sarah
    Ong, Hui Ching
    Garcia, Andrea Gomez
    Campoy, Sergio
    Sanahuja, Jordi
    Cabral, Goncalo
    Blasco, Isabel Beltran
    Waliszewska-Prosol, Marta
    Pereira, Liliana
    Layos-Romero, Almudena
    Luzeiro, Isabel
    Dorado, Laura
    Escudero, Maria Rocio Alvarez
    May, Arne
    Lopez-Bravo, Alba
    Martins, Isabel Pavao
    Sundal, Christina
    Irimia, Pablo
    Ros, Alberto Lozano
    Gago-Veiga, Ana Beatriz
    Juanes, Fernando Velasco
    Ruscheweyh, Ruth
    Sacco, Simona
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2024, 95 (10): : 927 - 937
  • [42] Real-world effectiveness of fremanezumab in patients with migraine switching from another mAb targeting the CGRP pathway
    Waliszewska-Prosol, Marta
    Martelletti, Paolo
    DENTAL AND MEDICAL PROBLEMS, 2024, 61 (01) : 9 - 11
  • [43] Efficacy of eptinezumab in non-responders to subcutaneous monoclonal antibodies against CGRP and the CGRP receptor: A retrospective cohort study
    Triller, Paul
    Blessing, Virginia N.
    Overeem, Lucas H.
    Fitzek, Mira P.
    Hong, Ja Bin
    Lange, Kristin S.
    Reuter, Uwe
    Raffaelli, Bianca
    CEPHALALGIA, 2024, 44 (10)
  • [44] Real-world evidence for chronic migraine control in patients receiving treatment with CGRP mAbs and onabotulinumtoxinA
    Blumenfeld, A.
    Frishberg, B.
    Schim, J.
    Hughes, O.
    Sommer, K.
    Adams, A. Manack
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 152 - 153
  • [45] Real-world effectiveness of erenumab in Japanese patients with migraine
    Suzuki, Keisuke
    Suzuki, Shiho
    Shiina, Tomohiko
    Haruyama, Yasuo
    Kobayashi, Saro
    Shioda, Mukuto
    Hirata, Koichi
    HELIYON, 2024, 10 (04)
  • [46] Brazilian descriptive study of 104 consecutive real-world migraine patients treated with monoclonal antibodies
    Krymchantowski, Abouch
    Silva-Neto, Raimundo Pereira
    Jevoux, Carla
    Krymchantowski, Ana Gabriela
    POSTGRADUATE MEDICINE, 2022, 134 (06) : 598 - 602
  • [47] Effectiveness and safety of CGRP-mAbs in menstrual related migraine: a real-world experience
    Dortucci, V.
    Silvestro, M.
    Orologio, I.
    Tessitore, A.
    Tedeschi, G.
    Russo, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 273 - 273
  • [48] Effectiveness and safety of CGRP-mAbs in menstrual related migraine: A real-world experience
    Orologio, Ilaria
    Silvestro, Marcello
    Tessitore, Alessandro
    Bonavita, Simona
    Di Clemente, Fabrizio Scotto
    Fasano, Carla
    Tedeschi, Gioacchino
    Russo, Antonio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 196 - 197
  • [49] REAL-WORLD EFFECTIVENESS OF MONOCLONAL ANTIBODIES FOR PATIENTS WITH MULTIPLE MYELOMA: A SYSTEMATIC LITERATURE REVIEW
    Lai, J. H.
    Kenawy, A. S.
    Aiyeolemi, A. A.
    Russo, A. J.
    Sohn, T. J.
    Chen, S.
    Rascati, K. L.
    Avancena, A. L., V
    VALUE IN HEALTH, 2023, 26 (06) : S37 - S37
  • [50] CGRP Monoclonal Antibodies in the Treatment of Migraine in Elderly Patients: A Single Center Experience
    Patel, P.
    Lee, M.
    Shadbehr, N.
    Kriegler, J. S.
    Mays, M.
    Burstein, T.
    Ahmed, Z.
    HEADACHE, 2020, 60 : 8 - 8